ARTESE, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 665
EU - Europa 147
AS - Asia 101
OC - Oceania 5
SA - Sud America 4
AF - Africa 1
Totale 923
Nazione #
US - Stati Uniti d'America 665
SG - Singapore 51
DE - Germania 31
IT - Italia 30
IE - Irlanda 26
RU - Federazione Russa 12
IR - Iran 11
UA - Ucraina 10
CN - Cina 9
GB - Regno Unito 9
CZ - Repubblica Ceca 6
SE - Svezia 6
IN - India 5
VN - Vietnam 5
BE - Belgio 4
ID - Indonesia 4
JP - Giappone 4
FI - Finlandia 3
HK - Hong Kong 3
MY - Malesia 3
NZ - Nuova Zelanda 3
AU - Australia 2
BR - Brasile 2
ES - Italia 2
FR - Francia 2
KR - Corea 2
NL - Olanda 2
PL - Polonia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CL - Cile 1
GR - Grecia 1
MA - Marocco 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
TR - Turchia 1
Totale 923
Città #
Wilmington 197
Woodbridge 127
Houston 86
Singapore 47
Chandler 45
Fairfield 32
Ann Arbor 16
Dublin 16
Ashburn 15
Rome 15
Santa Clara 11
Seattle 11
Jacksonville 9
Medford 8
New York 7
Munich 6
Brno 5
Cagliari 5
Cambridge 5
Brussels 4
Jakarta 4
Lawrence 4
Palo Alto 4
Auckland 3
Beijing 3
Croydon 3
Dearborn 3
Dong Ket 3
Kuala Lumpur 3
Zhengzhou 3
Boardman 2
Cedarhurst 2
Council Bluffs 2
Creede 2
Hanoi 2
Hong Kong 2
Lucknow 2
Menlo Park 2
Milan 2
Moscow 2
Mumbai 2
Mülheim 2
Norwalk 2
Nuremberg 2
Philadelphia 2
Phoenix 2
Redwood City 2
San Francisco 2
São Paulo 2
Tokyo 2
A Coruña 1
Albano Laziale 1
Amsterdam 1
Canberra 1
Cascina 1
Central District 1
Dubai 1
Helsinki 1
Kraków 1
Kunming 1
La Plata 1
Lahore 1
London 1
Los Angeles 1
Manchester 1
Manila 1
Manitou Springs 1
Monza 1
Mountain View 1
Osaka 1
Prague 1
Rotterdam 1
San Diego 1
San Giorgio A Cremano 1
San Mateo 1
Stockholm 1
Sydney 1
University Park 1
Warsaw 1
Totale 769
Nome #
Effect of maraviroc on non-R5 tropic HIV-1: Refined analysis of subjects from the phase IIb study A4001029 421
New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T) 189
Computational studies of mutations associated to resistance in HIV-1 macromolecular targets and implications in rational design of novel antiviral agents 135
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control 73
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses 44
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 41
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 18
null 17
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach 5
Totale 943
Categoria #
all - tutte 3.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020119 0 0 0 0 0 22 24 16 16 15 10 16
2020/2021147 12 14 9 15 12 13 32 19 4 4 7 6
2021/202259 0 3 0 6 2 5 14 6 5 4 4 10
2022/2023128 29 11 4 14 8 19 8 14 13 1 4 3
2023/202459 5 1 2 1 2 7 5 13 12 2 3 6
2024/2025138 16 42 32 19 6 23 0 0 0 0 0 0
Totale 943